Order Article Reprints

Virgili Manrique AC, Salazar J, Arranz MJ, Bagué S, Orellana R, López-Pousa A, Cerdà P, Gracia I, Majercakova K, Peiró A, et al. Pharmacogenetic Profiling in High-Risk Soft Tissue Sarcomas Treated with Neoadjuvant Chemotherapy. Journal of Personalized Medicine. 2022; 12(4):618. https://doi.org/10.3390/jpm12040618

Virgili Manrique, Anna C., Juliana Salazar, María Jesús Arranz, Silvia Bagué, Ruth Orellana, Antonio López-Pousa, Paula Cerdà, Isidre Gracia, Katarina Majercakova, Ana Peiró, and et al. 2022. "Pharmacogenetic Profiling in High-Risk Soft Tissue Sarcomas Treated with Neoadjuvant Chemotherapy" Journal of Personalized Medicine 12, no. 4: 618. https://doi.org/10.3390/jpm12040618

Virgili Manrique, A. C., Salazar, J., Arranz, M. J., Bagué, S., Orellana, R., López-Pousa, A., Cerdà, P., Gracia, I., Majercakova, K., Peiró, A., Trullols, L., Fernández, M., Valverde, S., Quintana, M. J., Bell, O., Artigas-Baleri, A., & Sebio, A. (2022). Pharmacogenetic Profiling in High-Risk Soft Tissue Sarcomas Treated with Neoadjuvant Chemotherapy. Journal of Personalized Medicine, 12(4), 618. https://doi.org/10.3390/jpm12040618